Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Completed × baricitinib × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 1

Interventions

Cyclophosphamide 257 Cisplatin 247 Radiotherapy 224 Paclitaxel 214 Docetaxel 196 Carboplatin 193 Fluorouracil 192 Doxorubicin 189 Dexamethasone 147 Gemcitabine 133 Vincristine 124 Capecitabine 115 Prednisone 112 Etoposide 111 Leucovorin 107 Methotrexate 103 Bevacizumab 102 Rituximab 97 Cytarabine 95 Filgrastim 84 Trastuzumab 81 Oxaliplatin 76 pembrolizumab 68 Pemetrexed 61 Drug Therapy 61 Tamoxifen 60 Epirubicin 57 Irinotecan 53 Chemotherapy, Adjuvant 52 Granulocyte Colony-Stimulating Factor 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01721044 2019-09-18

RA-BEACON

Eli Lilly and Company

Phase 3 Completed

527 enrolled 37 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡